Hims vs Henry Meds: Broad Platform vs Detailed Pricing

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, where we compare GLP-1 telehealth programs and the genetics that sit beneath them. Browse all Peptides & GLP-1 education

This is an independent editorial comparison. PlexusDx has no commercial relationship with Hims or Henry Meds and receives no affiliate compensation.

Full head-to-head: PlexusDx vs Henry Meds →

Hims and Henry Meds occupy opposite ends of the telehealth spectrum: one a sprawling consumer-health subscription, the other a metabolic-focused compounding program. This comparison sets Henry's detailed published pricing against Hims's broader model and closes with the factor neither captures. Henry figures verified July 20, 2026; context as of April 2026.

Scale versus specialization

Hims is the men's-facing arm of Hims & Hers Health, a large subscription-telehealth company covering many categories, with weight management one line within it. Henry Meds is a narrower telehealth-plus-compounding program built around metabolic care. Both run virtual evaluations and dispense branded or compounded GLP-1s, but the experience of a broad platform differs from a focused one.

Henry Meds pricing in detail

Henry prices per medication and advertises a low headline that requires paying twelve months up front, so its month-to-month rate is higher. Injectable compounded semaglutide, its flagship, is $297/month month-to-month; prepaid plans lower it to $247/month on the 6-month plan ($1,482) or $197/month on the 12-month plan ($2,364 paid in full) — that last figure is the advertised "$197/month." Sublingual semaglutide runs $249/month, with a $179/month tier. Tirzepatide is oral only, sold as a 3-month supply at $1,047 ($891 paid in full), with no month-to-month rate; there is no injectable tirzepatide as of July 2026. Liraglutide is $179/month and phentermine $149/month. There is no membership or consultation fee, and the refund policy is not stated.

How Hims prices, and why we don't quote it

Hims publishes its own weight-management pricing on its site, folded into its broader membership structure. Rather than cite a number that may already be stale, verify Hims's current rates directly before any purchase decision. Confirm Henry's figures on Henry Meds's official website as well.

Format and access differences

The practical split is format and menu: Henry offers injectable semaglutide but only oral tirzepatide, while Hims folds GLP-1 options into a larger catalog spanning many needs. Dispensing pathway (branded versus compounded), provider type, and subscription structure all vary. Read each brand's current lineup on its own site before deciding.

Same drug class, different genetic starting line

Neither brand changes the compound class: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual agonist tirzepatide, evidenced by STEP (NEJM, 2021), SURMOUNT (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024). What varies between people is genetic. Variants in MC4R, FTO, GLP1R, and TCF7L2 chart the metabolic baseline any GLP-1 acts on — context neither Hims nor Henry Meds measures.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — Semaglutide Injection at $189/month, Tirzepatide Injection at $289/month, plus Semaglutide Oral and Tirzepatide Oral. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights and does not predict response to any specific medication.

Not affiliated: PlexusDx is independent of both Hims and Henry Meds and has no commercial relationship with the companies reviewed here.

Related reading on PlexusDx: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.

Disclaimer: This article is educational. PlexusDx is not affiliated with Hims or Henry Meds and has no commercial relationship with the companies reviewed. PlexusDx offers its own Weight Management Protocols, so this piece compares approaches within the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before starting any peptide protocol.

Compare the approach: see the Weight Management Protocols, or start with the Precision Peptide Genetic Test.

Frequently Asked Questions

What does Henry Meds charge for its GLP-1 program?

As verified July 20, 2026, Henry's injectable semaglutide is $297/month month-to-month, reaching the advertised $197/month only with a twelve-month prepay of $2,364. Sublingual semaglutide is $249/month, oral tirzepatide is $1,047 per 3-month supply, and liraglutide and phentermine are $179 and $149/month respectively.

Why doesn't this review list Hims's price?

Hims publishes weight-management pricing within its broader membership, and those figures change often. Rather than quote a number that may already be outdated, we point you to verify Hims's current rates directly on its site, which keeps this comparison accurate rather than risking a stale figure.

Does Henry Meds offer injectable tirzepatide?

No. As of July 2026, Henry Meds offers tirzepatide in oral (dissolving tablet) form only, sold as a 3-month supply at $1,047 ($891 paid in full), with no month-to-month rate. Its injectable option is semaglutide. Confirm the current menu on Henry's own site.

Where does genetics fit into this comparison?

Neither Hims nor Henry Meds evaluates your genetic baseline. The Precision Peptide Genetic Test analyzes pathway-level variants in MC4R and FTO, and TCF7L2 that describe your metabolic starting line. It does not predict response but supplies context that applies whichever program you pick.

More in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.